There is a Webinar on 5/29 discussing clinical trials for COVID-19/ARDS; we would like our study listed as we have FDA IND approval and are currently in the final stages of start up at 3-4 sites nationwide.

Go to the profile of Kevin N. Ramdas
Kevin N. Ramdas on May 14, 2020 • 1 answer
• 0
We have FDA IND approval as of 4/4/20, Central IRB approval 4/16/20 and will begin enrolling subjects at the following centers as study start up is almost complete: Miami VA Healthsystem, Wake Forest University, and University of Maryland. This study is utilizing Longeveron Mesenchymal Stem Cells (LMSC) via Intravenous Infusion for Moderate to Severe ARDS in COVID + patients. The Recover Trial. Please contact me for additional information Kevin N. Ramdas, Associate Director, Medical Affairs, kramdas@longeveron.com

Answers

Thanks for letting us know, Kevin - I've passed on your information to the editor involved with producing this panel. Freya

Go to the profile of RegMedNet
RegMedNet on May 14, 2020
• 0